We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drais Pharmaceuticals and Diatos Partner to Develop and Commercialize DTS-108 for Treatment of Cancer

News   Dec 23, 2008

 
Drais Pharmaceuticals and Diatos Partner to Develop and Commercialize DTS-108 for Treatment of Cancer
 
 
 

RELATED ARTICLES

Saliva-based Alzheimer's Test Could be the Future

News

Three biomarkers for detecting mild cognitive impairment and Alzheimer’s disease in saliva samples have been identified.

READ MORE

Statins Have Low Risk of Side Effects

News

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.

READ MORE

Multigene Test Facilitates Targeted Use of Chemotherapy for Breast Cancer

News

New results show that the multigene test used at the university hospital in Munich is indeed helpful in making more targeted use of chemotherapy treatments and thus improves prognosis of breast cancer patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE